Pfizer is partnering in unique ways in APAC

We are working on collaborative models such as the Centers for Therapeutic innovations, where `we bring together a number of academic institutions with our scientists to solve specific issues or problems in scientific research. We have these centers in Boston, in New York and in California. We are excited about this new model to bring the academic and private sectors together.

We are partnering in ways that are unique. There are many examples, but one of my favorites is our relationship with the Cystic Fibrosis Foundation, the patient advocacy organization. In that partnership we are bringing our expertise, technical work and experience in this space to match with a substantial financial investment on the part of the Foundation, $58 million, and their expertise and links to Cystic Fibrosis patient communities. This is an exciting way to move CF treatment forward.